Gender Differences in Sexual Biomarkers and Behaviors Associated With Human Papillomavirus-16, -18, and -33 Seroprevalence

Background: The elevated risk for incident head and neck cancer among human papillomavirus (HPV)-16-seropositive individuals has substantiated a role for HPV in the etiology of head and neck cancers. The relationship between HPV seroreactivity and prevalent oral HPV infection in men and women withou...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Sexually transmitted diseases 2004-04, Vol.31 (4), p.247-256
Hauptverfasser: KREIMER, AIMEE R., ALBERG, ANTHONY J., VISCIDI, RAPHEAL, GILLISON, MAURA L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 256
container_issue 4
container_start_page 247
container_title Sexually transmitted diseases
container_volume 31
creator KREIMER, AIMEE R.
ALBERG, ANTHONY J.
VISCIDI, RAPHEAL
GILLISON, MAURA L.
description Background: The elevated risk for incident head and neck cancer among human papillomavirus (HPV)-16-seropositive individuals has substantiated a role for HPV in the etiology of head and neck cancers. The relationship between HPV seroreactivity and prevalent oral HPV infection in men and women without cancer has yet to be investigated. Goal: The goal of this study was to evaluate a possible association between oral HPV infection and HPV seroreactivity after adjustment for gender, sexual behaviors, and sexually transmitted disease. Study Design: A cross-sectional study of factors associated with HPV-16, -18, and -33 seroreactivity was performed in a population of 586 men and women with and without HIV infection. Antibodies in sera were measured by use of a virus-like protein (VLP)-based enzyme-linked immunosorbent assay. Exfoliated cells from the tonsillar and oral mucosa were analyzed for the presence of 38 mucosal HPV types by polymerase chain reaction. Results: Women had significantly greater seroreactivity for all HPV types investigated when compared with men (odds ratio, 4.3; 95% confidence interval, 3.0-6.0). Seroprevalence was greatest in men and women aged 35 to 45 years. Tonsillar HPV infection, oral sex with men, and HIV infection were independently associated with HPV seroreactivity in men after adjustment for age and number of sexual partners. In women, HSV-2 seropositivity and a history of sexually transmitted diseases were similarly important. Oral and tonsillar HPV infection were not associated with HPV seroreactivity in women. Conclusion: HPV seropositivity is associated with sexually transmitted diseases among women and possibly mucosal HPV exposures in men. Tonsillar HPV infection could impact seroprevalence, particularly in men.
doi_str_mv 10.1097/01.OLQ.0000118425.49522.2C
format Article
fullrecord <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_71729832</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>44966233</jstor_id><sourcerecordid>44966233</sourcerecordid><originalsourceid>FETCH-LOGICAL-c449c-a67fb53d54832204c036c83068ddee35f8ba4e587d7997cec800d1c4f05a70063</originalsourceid><addsrcrecordid>eNqFkU9vEzEQxS0EoqHwEUBWJTh1w_i_t7c2QIsUqSBAHC3HO6s6bHaDnY1aPj1OE1HEBV-s0fzejOY9Qk4YTBnU5i2w6fX88xTKY8xKrqayVpxP-ewRmTAlTCUVZ4_JBJi0lTLMHJFnOS9hVwN7So6YAm5rySbk1yX2DSb6LrYtJuwDZhp7-gVvR9_RizisfPqBKVPfN_QCb_w2DqU6z3kI0W-wod_j5oZejSvf009-HbuuSLYxjbli-pRWzJ7eayshytQ0rBNufbdb9Jw8aX2X8cXhPybfPrz_Oruq5teXH2fn8ypIWYfKa9MulGiUtIJzkAGEDlaAtk2DKFRrF16isqYxdW0CBgvQsCBbUN4AaHFM3uznrtPwc8S8cauYA3ad73EYsyv-8LrM_i_ITLFZC1XAk3_A5TCmvhzhOOfCSA27aWd7KKQh54StW6dY3LxzDNwuRwfMlRzdQ47uPkfHZ0X86rBhXKyweZAegivA6wPgc_Bdm3wfYv6L07ycLgr3cs8t82ZIf_rFWa156f8G5kqtrg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>222374602</pqid></control><display><type>article</type><title>Gender Differences in Sexual Biomarkers and Behaviors Associated With Human Papillomavirus-16, -18, and -33 Seroprevalence</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><source>JSTOR Archive Collection A-Z Listing</source><creator>KREIMER, AIMEE R. ; ALBERG, ANTHONY J. ; VISCIDI, RAPHEAL ; GILLISON, MAURA L.</creator><creatorcontrib>KREIMER, AIMEE R. ; ALBERG, ANTHONY J. ; VISCIDI, RAPHEAL ; GILLISON, MAURA L.</creatorcontrib><description>Background: The elevated risk for incident head and neck cancer among human papillomavirus (HPV)-16-seropositive individuals has substantiated a role for HPV in the etiology of head and neck cancers. The relationship between HPV seroreactivity and prevalent oral HPV infection in men and women without cancer has yet to be investigated. Goal: The goal of this study was to evaluate a possible association between oral HPV infection and HPV seroreactivity after adjustment for gender, sexual behaviors, and sexually transmitted disease. Study Design: A cross-sectional study of factors associated with HPV-16, -18, and -33 seroreactivity was performed in a population of 586 men and women with and without HIV infection. Antibodies in sera were measured by use of a virus-like protein (VLP)-based enzyme-linked immunosorbent assay. Exfoliated cells from the tonsillar and oral mucosa were analyzed for the presence of 38 mucosal HPV types by polymerase chain reaction. Results: Women had significantly greater seroreactivity for all HPV types investigated when compared with men (odds ratio, 4.3; 95% confidence interval, 3.0-6.0). Seroprevalence was greatest in men and women aged 35 to 45 years. Tonsillar HPV infection, oral sex with men, and HIV infection were independently associated with HPV seroreactivity in men after adjustment for age and number of sexual partners. In women, HSV-2 seropositivity and a history of sexually transmitted diseases were similarly important. Oral and tonsillar HPV infection were not associated with HPV seroreactivity in women. Conclusion: HPV seropositivity is associated with sexually transmitted diseases among women and possibly mucosal HPV exposures in men. Tonsillar HPV infection could impact seroprevalence, particularly in men.</description><identifier>ISSN: 0148-5717</identifier><identifier>EISSN: 1537-4521</identifier><identifier>DOI: 10.1097/01.OLQ.0000118425.49522.2C</identifier><identifier>PMID: 15028941</identifier><identifier>CODEN: STRDDM</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott Williams &amp; Wilkins</publisher><subject>Adolescent ; Adult ; Age Factors ; Baltimore - epidemiology ; Biological and medical sciences ; Biomarkers ; Cancer ; Cross-Sectional Studies ; Dermatology ; DNA, Viral - analysis ; Female ; Fundamental and applied biological sciences. Psychology ; Gender Identity ; General aspects ; Head and Neck Neoplasms - virology ; HIV ; HIV Infections ; Human immunodeficiency virus ; Human infectious diseases. Experimental studies and models ; Human papillomavirus 16 ; Human papillomavirus 33 ; Humans ; Immunoassay ; Infectious diseases ; Male ; Medical sciences ; Microbiology ; Middle Aged ; Mouth Diseases - blood ; Mouth Diseases - epidemiology ; Mouth Diseases - virology ; Mucous membrane ; Papillomaviridae - classification ; Papillomaviridae - genetics ; Papillomaviridae - isolation &amp; purification ; Papillomavirus Infections - blood ; Papillomavirus Infections - epidemiology ; Papillomavirus Infections - virology ; Risk Factors ; Seroepidemiologic Studies ; Sexual Behavior ; Sexually transmitted diseases ; STD ; Surveys and Questionnaires ; Tonsillar Neoplasms - virology ; Tumor Virus Infections - blood ; Tumor Virus Infections - epidemiology ; Tumor Virus Infections - virology</subject><ispartof>Sexually transmitted diseases, 2004-04, Vol.31 (4), p.247-256</ispartof><rights>Copyright © 2004 American Sexually Transmitted Diseases Association</rights><rights>2004 INIST-CNRS</rights><rights>Copyright Lippincott Williams &amp; Wilkins Apr 2004</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c449c-a67fb53d54832204c036c83068ddee35f8ba4e587d7997cec800d1c4f05a70063</citedby><cites>FETCH-LOGICAL-c449c-a67fb53d54832204c036c83068ddee35f8ba4e587d7997cec800d1c4f05a70063</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/44966233$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/44966233$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,803,27924,27925,30999,58017,58250</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15620633$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15028941$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>KREIMER, AIMEE R.</creatorcontrib><creatorcontrib>ALBERG, ANTHONY J.</creatorcontrib><creatorcontrib>VISCIDI, RAPHEAL</creatorcontrib><creatorcontrib>GILLISON, MAURA L.</creatorcontrib><title>Gender Differences in Sexual Biomarkers and Behaviors Associated With Human Papillomavirus-16, -18, and -33 Seroprevalence</title><title>Sexually transmitted diseases</title><addtitle>Sex Transm Dis</addtitle><description>Background: The elevated risk for incident head and neck cancer among human papillomavirus (HPV)-16-seropositive individuals has substantiated a role for HPV in the etiology of head and neck cancers. The relationship between HPV seroreactivity and prevalent oral HPV infection in men and women without cancer has yet to be investigated. Goal: The goal of this study was to evaluate a possible association between oral HPV infection and HPV seroreactivity after adjustment for gender, sexual behaviors, and sexually transmitted disease. Study Design: A cross-sectional study of factors associated with HPV-16, -18, and -33 seroreactivity was performed in a population of 586 men and women with and without HIV infection. Antibodies in sera were measured by use of a virus-like protein (VLP)-based enzyme-linked immunosorbent assay. Exfoliated cells from the tonsillar and oral mucosa were analyzed for the presence of 38 mucosal HPV types by polymerase chain reaction. Results: Women had significantly greater seroreactivity for all HPV types investigated when compared with men (odds ratio, 4.3; 95% confidence interval, 3.0-6.0). Seroprevalence was greatest in men and women aged 35 to 45 years. Tonsillar HPV infection, oral sex with men, and HIV infection were independently associated with HPV seroreactivity in men after adjustment for age and number of sexual partners. In women, HSV-2 seropositivity and a history of sexually transmitted diseases were similarly important. Oral and tonsillar HPV infection were not associated with HPV seroreactivity in women. Conclusion: HPV seropositivity is associated with sexually transmitted diseases among women and possibly mucosal HPV exposures in men. Tonsillar HPV infection could impact seroprevalence, particularly in men.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age Factors</subject><subject>Baltimore - epidemiology</subject><subject>Biological and medical sciences</subject><subject>Biomarkers</subject><subject>Cancer</subject><subject>Cross-Sectional Studies</subject><subject>Dermatology</subject><subject>DNA, Viral - analysis</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gender Identity</subject><subject>General aspects</subject><subject>Head and Neck Neoplasms - virology</subject><subject>HIV</subject><subject>HIV Infections</subject><subject>Human immunodeficiency virus</subject><subject>Human infectious diseases. Experimental studies and models</subject><subject>Human papillomavirus 16</subject><subject>Human papillomavirus 33</subject><subject>Humans</subject><subject>Immunoassay</subject><subject>Infectious diseases</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Microbiology</subject><subject>Middle Aged</subject><subject>Mouth Diseases - blood</subject><subject>Mouth Diseases - epidemiology</subject><subject>Mouth Diseases - virology</subject><subject>Mucous membrane</subject><subject>Papillomaviridae - classification</subject><subject>Papillomaviridae - genetics</subject><subject>Papillomaviridae - isolation &amp; purification</subject><subject>Papillomavirus Infections - blood</subject><subject>Papillomavirus Infections - epidemiology</subject><subject>Papillomavirus Infections - virology</subject><subject>Risk Factors</subject><subject>Seroepidemiologic Studies</subject><subject>Sexual Behavior</subject><subject>Sexually transmitted diseases</subject><subject>STD</subject><subject>Surveys and Questionnaires</subject><subject>Tonsillar Neoplasms - virology</subject><subject>Tumor Virus Infections - blood</subject><subject>Tumor Virus Infections - epidemiology</subject><subject>Tumor Virus Infections - virology</subject><issn>0148-5717</issn><issn>1537-4521</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><recordid>eNqFkU9vEzEQxS0EoqHwEUBWJTh1w_i_t7c2QIsUqSBAHC3HO6s6bHaDnY1aPj1OE1HEBV-s0fzejOY9Qk4YTBnU5i2w6fX88xTKY8xKrqayVpxP-ewRmTAlTCUVZ4_JBJi0lTLMHJFnOS9hVwN7So6YAm5rySbk1yX2DSb6LrYtJuwDZhp7-gVvR9_RizisfPqBKVPfN_QCb_w2DqU6z3kI0W-wod_j5oZejSvf009-HbuuSLYxjbli-pRWzJ7eayshytQ0rBNufbdb9Jw8aX2X8cXhPybfPrz_Oruq5teXH2fn8ypIWYfKa9MulGiUtIJzkAGEDlaAtk2DKFRrF16isqYxdW0CBgvQsCBbUN4AaHFM3uznrtPwc8S8cauYA3ad73EYsyv-8LrM_i_ITLFZC1XAk3_A5TCmvhzhOOfCSA27aWd7KKQh54StW6dY3LxzDNwuRwfMlRzdQ47uPkfHZ0X86rBhXKyweZAegivA6wPgc_Bdm3wfYv6L07ycLgr3cs8t82ZIf_rFWa156f8G5kqtrg</recordid><startdate>200404</startdate><enddate>200404</enddate><creator>KREIMER, AIMEE R.</creator><creator>ALBERG, ANTHONY J.</creator><creator>VISCIDI, RAPHEAL</creator><creator>GILLISON, MAURA L.</creator><general>Lippincott Williams &amp; Wilkins</general><general>Lippincott</general><general>Lippincott Williams &amp; Wilkins Ovid Technologies</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope><scope>7QL</scope><scope>7T2</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>200404</creationdate><title>Gender Differences in Sexual Biomarkers and Behaviors Associated With Human Papillomavirus-16, -18, and -33 Seroprevalence</title><author>KREIMER, AIMEE R. ; ALBERG, ANTHONY J. ; VISCIDI, RAPHEAL ; GILLISON, MAURA L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c449c-a67fb53d54832204c036c83068ddee35f8ba4e587d7997cec800d1c4f05a70063</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age Factors</topic><topic>Baltimore - epidemiology</topic><topic>Biological and medical sciences</topic><topic>Biomarkers</topic><topic>Cancer</topic><topic>Cross-Sectional Studies</topic><topic>Dermatology</topic><topic>DNA, Viral - analysis</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gender Identity</topic><topic>General aspects</topic><topic>Head and Neck Neoplasms - virology</topic><topic>HIV</topic><topic>HIV Infections</topic><topic>Human immunodeficiency virus</topic><topic>Human infectious diseases. Experimental studies and models</topic><topic>Human papillomavirus 16</topic><topic>Human papillomavirus 33</topic><topic>Humans</topic><topic>Immunoassay</topic><topic>Infectious diseases</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Microbiology</topic><topic>Middle Aged</topic><topic>Mouth Diseases - blood</topic><topic>Mouth Diseases - epidemiology</topic><topic>Mouth Diseases - virology</topic><topic>Mucous membrane</topic><topic>Papillomaviridae - classification</topic><topic>Papillomaviridae - genetics</topic><topic>Papillomaviridae - isolation &amp; purification</topic><topic>Papillomavirus Infections - blood</topic><topic>Papillomavirus Infections - epidemiology</topic><topic>Papillomavirus Infections - virology</topic><topic>Risk Factors</topic><topic>Seroepidemiologic Studies</topic><topic>Sexual Behavior</topic><topic>Sexually transmitted diseases</topic><topic>STD</topic><topic>Surveys and Questionnaires</topic><topic>Tonsillar Neoplasms - virology</topic><topic>Tumor Virus Infections - blood</topic><topic>Tumor Virus Infections - epidemiology</topic><topic>Tumor Virus Infections - virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>KREIMER, AIMEE R.</creatorcontrib><creatorcontrib>ALBERG, ANTHONY J.</creatorcontrib><creatorcontrib>VISCIDI, RAPHEAL</creatorcontrib><creatorcontrib>GILLISON, MAURA L.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Sexually transmitted diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>KREIMER, AIMEE R.</au><au>ALBERG, ANTHONY J.</au><au>VISCIDI, RAPHEAL</au><au>GILLISON, MAURA L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gender Differences in Sexual Biomarkers and Behaviors Associated With Human Papillomavirus-16, -18, and -33 Seroprevalence</atitle><jtitle>Sexually transmitted diseases</jtitle><addtitle>Sex Transm Dis</addtitle><date>2004-04</date><risdate>2004</risdate><volume>31</volume><issue>4</issue><spage>247</spage><epage>256</epage><pages>247-256</pages><issn>0148-5717</issn><eissn>1537-4521</eissn><coden>STRDDM</coden><abstract>Background: The elevated risk for incident head and neck cancer among human papillomavirus (HPV)-16-seropositive individuals has substantiated a role for HPV in the etiology of head and neck cancers. The relationship between HPV seroreactivity and prevalent oral HPV infection in men and women without cancer has yet to be investigated. Goal: The goal of this study was to evaluate a possible association between oral HPV infection and HPV seroreactivity after adjustment for gender, sexual behaviors, and sexually transmitted disease. Study Design: A cross-sectional study of factors associated with HPV-16, -18, and -33 seroreactivity was performed in a population of 586 men and women with and without HIV infection. Antibodies in sera were measured by use of a virus-like protein (VLP)-based enzyme-linked immunosorbent assay. Exfoliated cells from the tonsillar and oral mucosa were analyzed for the presence of 38 mucosal HPV types by polymerase chain reaction. Results: Women had significantly greater seroreactivity for all HPV types investigated when compared with men (odds ratio, 4.3; 95% confidence interval, 3.0-6.0). Seroprevalence was greatest in men and women aged 35 to 45 years. Tonsillar HPV infection, oral sex with men, and HIV infection were independently associated with HPV seroreactivity in men after adjustment for age and number of sexual partners. In women, HSV-2 seropositivity and a history of sexually transmitted diseases were similarly important. Oral and tonsillar HPV infection were not associated with HPV seroreactivity in women. Conclusion: HPV seropositivity is associated with sexually transmitted diseases among women and possibly mucosal HPV exposures in men. Tonsillar HPV infection could impact seroprevalence, particularly in men.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott Williams &amp; Wilkins</pub><pmid>15028941</pmid><doi>10.1097/01.OLQ.0000118425.49522.2C</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0148-5717
ispartof Sexually transmitted diseases, 2004-04, Vol.31 (4), p.247-256
issn 0148-5717
1537-4521
language eng
recordid cdi_proquest_miscellaneous_71729832
source MEDLINE; Journals@Ovid Complete; Applied Social Sciences Index & Abstracts (ASSIA); JSTOR Archive Collection A-Z Listing
subjects Adolescent
Adult
Age Factors
Baltimore - epidemiology
Biological and medical sciences
Biomarkers
Cancer
Cross-Sectional Studies
Dermatology
DNA, Viral - analysis
Female
Fundamental and applied biological sciences. Psychology
Gender Identity
General aspects
Head and Neck Neoplasms - virology
HIV
HIV Infections
Human immunodeficiency virus
Human infectious diseases. Experimental studies and models
Human papillomavirus 16
Human papillomavirus 33
Humans
Immunoassay
Infectious diseases
Male
Medical sciences
Microbiology
Middle Aged
Mouth Diseases - blood
Mouth Diseases - epidemiology
Mouth Diseases - virology
Mucous membrane
Papillomaviridae - classification
Papillomaviridae - genetics
Papillomaviridae - isolation & purification
Papillomavirus Infections - blood
Papillomavirus Infections - epidemiology
Papillomavirus Infections - virology
Risk Factors
Seroepidemiologic Studies
Sexual Behavior
Sexually transmitted diseases
STD
Surveys and Questionnaires
Tonsillar Neoplasms - virology
Tumor Virus Infections - blood
Tumor Virus Infections - epidemiology
Tumor Virus Infections - virology
title Gender Differences in Sexual Biomarkers and Behaviors Associated With Human Papillomavirus-16, -18, and -33 Seroprevalence
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T15%3A41%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gender%20Differences%20in%20Sexual%20Biomarkers%20and%20Behaviors%20Associated%20With%20Human%20Papillomavirus-16,%20-18,%20and%20-33%20Seroprevalence&rft.jtitle=Sexually%20transmitted%20diseases&rft.au=KREIMER,%20AIMEE%20R.&rft.date=2004-04&rft.volume=31&rft.issue=4&rft.spage=247&rft.epage=256&rft.pages=247-256&rft.issn=0148-5717&rft.eissn=1537-4521&rft.coden=STRDDM&rft_id=info:doi/10.1097/01.OLQ.0000118425.49522.2C&rft_dat=%3Cjstor_proqu%3E44966233%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=222374602&rft_id=info:pmid/15028941&rft_jstor_id=44966233&rfr_iscdi=true